Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUTEP LIMITED Capital/Financing Update 2010

Dec 9, 2010

65122_rns_2010-12-09_ec6aa1dc-288f-4941-ad06-097a1f59dcd3.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Appendix 3B New issue announcement

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New Issue Announcement, Application for Quotation of Additional Securities and Agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003, 24/10/2005.

Name of Entity:

Prima Biomed Limited (ASX: PRR)

ABN:

90 009 237 889

We (the entity) give ASX the following information.

Part 1 - All Issues

You must complete the relevant sections (attach sheets if there is not enough space).

1
+Class of+securities issued or to be
issued
2
Number of+securities issued or to
be issued (if known) or maximum
number which may be issued
3
Principal terms of the+securities
(eg, if options, exercise price and
expiry
date;
if
partly
paid
+securities, the amount outstanding
and due dates for payment; if
+convertible
securities,
the
conversion price and dates for
conversion)
a) Ordinary Fully Paid Shares (PRR)
b) Ordinary Fully Paid Shares (PRR)
c) Unlisted Options
d) Unlisted Options
a) 71,242
b) 1,250,000
c) 32,500,000
d) 2,000,000
a)&b) Pari passu with existing Ordinary Fully
Paid Shares (PRR)
c) Excise price $0.20 on or before 6 Dec. 2013
d) Excise price $0.10 on or before 6 Dec. 2014
  • See chapter 19 for defined terms.

24/10/2005

Appendix 3B Page 1

Appendix 3B New issue announcement

4 Do the[+] securities rank equally in all a) & b) Yes (PRR) respects from the date of allotment c) & d) Yes, on exercise of options. with an existing[+] class of quoted +securities? If the additional securities do not rank equally, please state: the date from which they do the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 5 Issue price or consideration a) $0.02 per share b) Directors’ services c) Directors’ services d) Employee services 6 Purpose of the issue a) Exercise of Options (If issued as consideration for the b) & c) & d) Issuance of shares and options to acquisition of assets, clearly identify directors as approved at the 2010 AGM held those assets) on 26 November 2010. 7 Dates of entering[+] securities into a) 10 December 2010 uncertificated holdings or despatch b) & c) & d) 6 December 2010 of certificates Number +Class 8 Number and +class of all 745,133,072 Ordinary fully paid shares (PRR) +securities quoted on ASX ( including the securities in clause 2 if applicable) 114,985,202 Options exercisable at $0.02 on or before 31 December 2011 (PRRO)

  • See chapter 19 for defined terms.

Appendix 3B Page 2

24/10/2005

Appendix 3B New issue announcement

9
Number and+class of
all
+securities
not
quoted
on
ASX
(including
the
securities in clause 2 if
applicable)
10
Dividend policy (in the
case
of
a
trust,
distribution policy) on
the increased capital
(interests)
**Number ** +Class +Class +Class
Amount Exercise
Price
Expiration Date ASX Code
15,000,000 $0.0629 20 July 2014 PRRAI
1,547,988 $0.1053 10 August 2014 PRRAM
1,766,784 $0.1325 9 September 2014 PRRAQ
1,884,253 $0.2231 10 October 2014 PRRAO
1,884,253 $0.2685 9 November 2014 PRRAS
1,884,253 $0.2360 8 December 2014 PRRAU
1,061,411 $0.2271 12 January 2015 PRRAY
1,118,211 $0.2345 12 February 2015 PRRAW
1,075,269 $0.2277 18 March 2015 PRRAZ
1,076,095 $0.2196 19 April 2015 PRRAA
100,000 $0.1000 1 February 2011 PRRAB
2,500,000 $0.2500 6 May 2015 PRRAC
1,055,011 $0.2351 19 May 2015 PRRAD
1,144,726 $0.2070 21 June 2015 PRRAE
1,722,017 $0.1605 21 July 2015 PRRAF
1,694,915 $0.1439 20 August 2015 PRRAK
1,741,294 $0.1414 22 September 2015 PRRAG
1,540,154 $0.1944 27 October 2015 PRRAH
1,315,789 $0.1893 24 November 2015 TBA
32,500,000 $0.2000 6 December 2013 TBA
2,000,000 $0.1000 6 December 2014 TBA
75,612,423 Total
Unchanged

Part 2 - Bonus Issue or Pro Rata Issue

  • 11 Is security holder approval required?

  • 12 Is the issue renounceable or nonrenounceable?

  • 13 Ratio in which the[+] securities will be offered

  • 14 +Class of +securities to which the offer relates

  • See chapter 19 for defined terms.

1/1/2003

Appendix 3B Page 3

Appendix 3B New issue announcement

15
+Record
date
to
determine
entitlements
16
Will holdings on different registers
(or subregisters) be aggregated for
calculating entitlements?
17
Policy for deciding entitlements in
relation to fractions
18
Names of countries in which the
entity has+security holders who
will
not
be
sent
new
issue
documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
19
Closing
date
for
receipt
of
acceptances or renunciations
20
Names of any underwriters
21
Amount of any underwriting fee or
commission
22
Names of any brokers to the issue
23
Fee or commission payable to the
broker to the issue
24
Amount
of
any
handling
fee
payable to brokers who lodge
acceptances or renunciations on
behalf of+security holders
25
If the issue is contingent on
+security holders’ approval, the date
of the meeting
26
Date entitlement and acceptance
form and prospectus or Product
Disclosure Statement will be sent to
persons entitled
27
If the entity has issued options, and
the terms entitle option holders to
participate on exercise, the date on
which notices will be sent to option
holders
28
Date rights trading will begin
  • See chapter 19 for defined terms.

Appendix 3B Page 4

24/10/2005

Appendix 3B New issue announcement

(if applicable)
29 Date rights trading will end
(if applicable)
30 How do+security holders sell their
entitlements_in full_through a
broker?
31 How do+security holders sell_part_
of their entitlements through a
broker and accept for the balance?
  • 32 How do[+] security holders dispose of their entitlements (except by sale through a broker)?

  • 33 +Despatch date

Part 3 - Quotation of Securities

You need only complete this section if you are applying for quotation of securities

  • 34 Type of securities ( tick one )

  • (a)[Securities described in Part 1 ]

  • (b)[All other securities ]

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

35[If the ][+][securities are ][+][equity securities, the names of the 20 largest holders of the ] additional[+] securities, and the number and percentage of additional[+] securities held by those holders 36 +[If the ] securities setting out the number of holders in the categories[+][securities are ][+][equity securities, a distribution schedule of the additional ] 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over

  • See chapter 19 for defined terms.

1/1/2003

Appendix 3B Page 5

Appendix 3B New issue announcement

37[A copy of any trust deed for the additional ][+][securities ] Entities that have ticked box 34(b)

38 Number of securities for which +quotation is sought 39 Class of +securities for which quotation is sought 40 Do the[+] securities rank equally in all respects from the date of allotment with an existing[+] class of quoted +securities? If the additional securities do not rank equally, please state: the date from which they do the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 41 Reason for request for quotation now Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another security, clearly identify that other security) Number +Class 42 Number and[+] class of all[+] securities quoted on ASX ( including the securities in clause 38)

  • See chapter 19 for defined terms.

Appendix 3B Page 6

24/10/2005

Appendix 3B New issue announcement

Quotation Agreement

  • 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

  • 2 We warrant the following to ASX.

==> picture [10 x 13] intentionally omitted <==

==> picture [10 x 13] intentionally omitted <==

==> picture [10 x 14] intentionally omitted <==

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted[+] quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

==> picture [10 x 13] intentionally omitted <==

==> picture [11 x 13] intentionally omitted <==

==> picture [10 x 14] intentionally omitted <==

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

  • We warrant that if confirmation is required under section 1017F of the Corporations Act in relation to the[+] securities to be quoted, it has been provided at the time that we request that the[+] securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before[+] quotation of the[+] securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

==> picture [351 x 89] intentionally omitted <==

----- Start of picture text -----

Sign Here:
Company Secretary Date: Friday, 10 December 2010
Print Name: Phillip Hains
----- End of picture text -----

==> picture [375 x 33] intentionally omitted <==

----- Start of picture text -----

The CFO Solution
10.12.2010
----- End of picture text -----

    • See chapter 19 for defined terms.

1/1/2003

Appendix 3B Page 7

==> picture [175 x 48] intentionally omitted <==

ASX ANNOUNCEMENT

Notice Under Section 708A(5) of the Corporations Act [ASX Code: PRR]

Friday 10 December 2010

This notice is given under paragraph (5)(e) of section 708A of the Corporations Act.

The Following securities of the Company were issued as approved at the 2010 AGM held on 26 November 2010.

Type: OrdinaryShares Unlisted Options Unlisted Options
Class/Description: Ordinary (Fully Paid) Exercisable at $0.20
on or before 6
December 2013
Exercisable at $0.10
on or before 6
December 2014
ASX Code: PRR To be advised To be advised
Date of Issue: 6 December 2010 6 December 2010 6 December 2010
Number Issued: 1,250,000 32,500,000 2,000,000
Issue Price per
Security:
Nil Cash Nil Cash Nil Cash

The Company intends to apply to Australian Stock Exchange Limited for quotation of the above shares.

Accordingly the Company gives notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) (the "Corporations Act") that:

  1. the abovementioned ordinary shares were issued without disclosure to investors under Part 6D.2 of the Corporations Act ;

  2. as at the date of this notice the Company has complied with:

  3. (i) the provisions of Chapter 2M Corporations Act as they apply to the Company; and

  4. (ii) section 674 Corporations Act ; and

  5. as at the date of this notice there is no "excluded information" (as defined in subsection 708A(7) of the Corporations Act) which is required to be disclosed by the Company.

For and on behalf of the Company,

==> picture [72 x 54] intentionally omitted <==

Phillip Hains Company Secretary